Anish Bhatnagar's Form 4 filing
Soleno Therapeutics Inc (SLNO) · filed Mar 31, 2025
- Accession no.
- 0001415889-25-009290
- Filed
- Mar 31, 2025
- Trade date
- Mar 27, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 18 non-derivative transactions and 6 derivative transactions. Open-market sales total $47.3M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Anish BhatnagarCIK 0001614821 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | Common Stock | SSaleDisposed | −14,183 | $65.97 | −$935,652.51 | 738,179 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −23,095 | $66.79 | −$1,542,515.05 | 715,084 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −41,989 | $67.70 | −$2,842,655.3 | 673,095 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −55,234 | $68.79 | −$3,799,546.86 | 617,861 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −31,980 | $69.84 | −$2,233,483.2 | 585,881 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −3,291 | $70.73 | −$232,772.43 | 582,590 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −4,782 | $71.74 | −$343,060.68 | 577,808 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −732 | $72.64 | −$53,172.48 | 577,076 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseAcquired | +26,606 | $24.00 | +$638,544 | 603,682 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseAcquired | +16,666 | $25.05 | +$417,483.3 | 620,348 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseAcquired | +105,000 | $33.60 | +$3,528,000 | 725,348 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseAcquired | +32,193 | $5.10 | +$164,184.3 | 757,541 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseAcquired | +62,291 | $2.41 | +$150,121.31 | 819,832 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseAcquired | +281,053 | $5.25 | +$1,475,528.25 | 1,100,885 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −106,471 | $65.81 | −$7,006,856.51 | 994,414 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −209,689 | $66.33 | −$13,908,671.37 | 784,725 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −8,423 | $67.37 | −$567,457.51 | 776,302 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −199,226 | $69.30 | −$13,806,361.8 | 577,076 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | Common Stock | MOption exerciseDisposed | −26,606 | $0.00 | $0 | 60 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseDisposed | −16,666 | $0.00 | $0 | 0 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseDisposed | −105,000 | $0.00 | $0 | 35,000 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseDisposed | −32,193 | $0.00 | $0 | 8,473 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseDisposed | −62,291 | $0.00 | $0 | 52,709 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseDisposed | −281,053 | $0.00 | $0 | 200,753 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.